once-weekly semaglutide in adults with alcohol use disorder RCT: reduces craving and consumption - Knopf - 2025 - Alcoholism & Drug Abuse Weekly Once-Weekly Semaglutide in Adults With

Wegovy has been approved by the FDA as a weight loss drug, while other drugs approved to treat type two diabetesincluding Ozempic or Mounjarohave been prescribed off-label for weight loss

Further, 43.7% of orforglipron recipients in cohort 1 maintained at least 80% of the weight loss achieved in SURMOUNT-5, compared to 16.4% of placebo recipients

However, as the body adapts to a lower weight, metabolic rate may decrease, and energy expenditure adjusts accordingly

There are several clinical reasons why a provider might prescribe semaglutide compounded with B12: Energy Support: Some individuals experience fatigue when starting a GLP-1 medication